Company Profile

Siloam Biosciences Inc
Profile last edited on: 6/26/19      CAGE: 335T6      UEI:

Business Identifier: Immunological diagnosis: biomedical point-of-care testing diagnostics,
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

413 Northland Boulevard
Cincinnati, OH 45240
   (513) 429-2976
Location: Single
Congr. District: 01
County: Hamilton

Public Profile

In May 2018 it was announced that MiCo BioMed, a KONEX-listed (Korean) company would acquire Siloam Biosciences, Inc.. MiCo BioMed, -- established in 2009 as NanoBioSys -- has developed molecular diagnostic products for virus infection by extracting genes and detecting bacteria in them and now manufactures and sells molecular diagnostic products and biochemical diagnostic products. The SBIR firm acquired - Siloam Biosciences - is a medical device company that had developed the first ever open source Point-of-Care Test platform: diagnostic kits and equipment based on a biomedical microelectromechanical systems (Bio MEMS) platform. Siloam's TROVA™ POCT platform allows for ultra-high sensitivity and wide dynamic range assays to be developed very quickly. The TROVA™ platform - driven by Siloam’s Optimiser™ technology platform - integrates the power of microfluidics in an easy-to-use pla

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Chong H Ahn -- President

  Jungyoup Jay Han -- Vice President of Product Development

  Junhai Kai

  Jae Y Lee

  Aniruddha P Puntambekar